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ABSTRACT

Nikumbh, Nayana M., M.S., Department of Biological Sciences, Wright State
University, 2014. Effects of Rev Protein on Microtubule Arrays in Living
Cells.
The HIV protein Rev regulates the expression of essential viral proteins
during the course of infection by a mechanism that is well understood. It
promotes nuclear export of viral transcripts, normally retained in the nucleus
owing to the presence of introns, by interacting with host cell transport factors.
However, over-expression of Rev in cells leads to defects in cell cycle
progression, specifically slowing growth and impairing progression through
mitosis (43). While it is possible that Rev may be altering the proteins in
transport pathways, cell cycle defects may be attributed to Rev’s interactions
with other proteins.
In vitro experiments show that highly purified Rev has a high and specific
affinity for α and β tubulin present either as free heterodimers or polymerized
into microtubules (MTs) (65). Moreover, Rev rapidly depolymerizes MTs in
vitro producing intermediates that closely resemble the products of
depolymerization reactions triggered by a variety of experimental conditions.
Owing to structural similarities, Rev hypothetically depolymerizes MTs by a
mechanism used by Kin-13 proteins that are potent MT depolymerizing
enzymes.
To determine whether Rev is interacting with MTs in a Kin-13-like manner,
point mutations were previously introduced into Rev substituting alanine for
iii

amino acids shared with Kin-13. Mutant proteins were tagged with YFP, overexpressed in HeLa cells and cell cycle progression was monitored by Chang
and Miller (27). In contrast to expression of Rev, which lengthened doubling
times and all stages of the cell cycle, each point mutant partially corrected the
defect. These results are consistent with Rev acting in a manner similar to
Kin-13. To determine whether Rev over-expression affects MT dynamics in
cells, MT arrays were experimentally depolymerized and allowed to recover.
If Rev inhibits MT nucleation or promotes depolymerization, then MT arrays
in cells expressing Rev should require more time to recover.
Results show that MT arrays recover from depolymerization equally well in
presence and absence of Rev. Because wild-type Rev accumulates largely in
the nucleus and nucleoli, we used Rev mutants M4, M6, and Rev2.2 with
mutations that impair Rev multimerization and nuclear import, and Rev
attached to glucocorticoid hormone receptor respectively. These mutants
typically maintain higher cytoplasmic expression levels than wild type Rev.
However, exogenous expression of Rev mutants does not affect MT recovery
after depolymerization. Furthermore, the ability of MTs to recovery after
cold-treatment in Rev expressing metaphase cells was also studied when Rev
localizes perichromosomally and is in a position to affect spindle behavior.
However, similar defects were observed in control cells suggesting there was
no consequence attributable to Rev. These results suggest that the cell cycle
defects observed in Rev-expressing cells are not mediated by Rev’s ability to
alter the polymerization state of MT. It therefore seems likely that cell cycle
defects caused by Rev must be mediated by its interactions with other
proteins, possibly B23 or Ran.

iv

TABLE OF CONTENTS

Introduction.................................................................................................. 1
Microtubule dynamics.................................................................................... 2
Rev................................................................................................................. 6
Rev function............................................................................................... 6
Rev interactions with MTs......................................................................... 8
Rev-tubulin interactions in vivo….............................................................10
Materials and Methods.............................................................................. 12
Cell Culture.................................................................................................. 12
Plasmid Isolation.......................................................................................... 12
Transfection.................................................................................................. 12
Cold depolymerization and recovery of MTs............................................... 13
Colchicine Depolymerization…................................................................... 13
Immunofluorescence Microscopy................................................................ 14
Quantifying MT Recovery After Depolymerization.................................... 14
Results......................................................................................................... 18
Microtubule recovery in Rev expressing cells............................................. 18
v

MT recovery in Rev mutants........................................................................ 26
RevM6 and control cells show similar rates of recovery after microtubule
depolymerization by cold ............................................................................ 27
RevM4 and control cells show similar recovery after microtubule
depolymerization by cold ............................................................................ 32
Rev2.2 expressing cells show insignificant difference in recovery of
microtubules compared to control cells........................................................ 37
MT recovery in Rev expressing mitotic cells............................................... 42

Discussion................................................................................................. 51
References................................................................................................. 54
Appendices............................................................................................... 64

vi

List of Figures
1. Estimating MT recovery by determining a Visual Array Index….... 17
2. Cellular localization of Rev……………….………………………...... 20
3. YFP and Rev expressing cells have similar MT recovery rates.......... 23
4. MT surface areas in Rev and YFP expressing cells recovering from
cold treatment are similar.……………..................................................... 25
5. RevM6 and control cells show similar rates of recovery after
microtubule depolymerization by cold ……………………………….... 29
6. RevM6 and control cells show similar growth of microtubule…....... 31
7. RevM4 and control cells show similar recovery after microtubule
depolymerization by cold……………………………............................... 34
8. RevM4 mutant show polymerization of MTs similar to YFP..…....... 36
9. Rev2.2 and control cells show similar recovery after microtubule
depolymerization by cold despite high levels of Rev in the cytoplasm.. 39
10. Rev2.2 mutant show polymerization of MTs similar to YFP…........ 41
11. YFP and Rev expressing metaphase ………….…………………..... 44
12. YFP and Rev expressing Metaphase cell after cold depolymerization
of spindle ……………………………………….………………………... 46

vii

13. YFP expressing Metaphase cells show chromosomal and spindle
formation abnormalities after recovery.…….…………..…………….... 48
14. Rev expressing Metaphase cells show chromosomal and spindle
formation abnormalities similar to YFP expressing cells after
recovery……………………..………………………................................. 50

viii

Acknowledgements
I would like to sincerely thank Dr. Miller, for allowing me do my masters
project in his lab and for being patient and understanding. He is one of the
best teachers that I have had: he kindly grants me his time even for answering
some of my unintelligent questions. I would also thank him to provide me
funding me in last semester of my masters.
I would like to thank Dr. Paula Bubulya for letting me use their lab
instruments, for providing me L-15 media doing my experiments, for being
my thesis committee member, and for giving suggestions in writing thesis
during my thesis committee meeting. I would also like to thank Dr. Shulin Ju,
for being on my thesis committee and his time.
I would like to thank Vishnu Priya Chowdary Battini for her moral and
emotional support throughout my project. Regardless of being not a member
of our lab, she helped me in troubleshooting and gave me her time. I would
also thank my all friends for their support through all the good times and
the bad.
Last but not the least, I would like to thank my dad Madhukar Nikumbh, my
mom Pushpa Nikumbh and my sister Shubhangi Gangurde for inspiring me
everytime and for supporting in my all decisions. I would also like thank my
brother Nikhil Nikumbh and sister Poonam Mokal invaluable support and
humor over the years.

ix

Introduction
The human immunodeficiency virus (HIV) is a causative agent of Acquired
Immune Deficiency Syndrome (AIDS) (66). It kills CD4+ T helper cells and
weakens the immune responses permitting opportunistic infections. It also
inhibits humoral immunity and B-cell functions (25). The HIV viral infection
cycle is closely linked to the cytoskeleton of the host cell and infection can
disrupt cytoskeletal arrays including both actin and microtubule arrays.
Epithelial cells infected with HIV have altered cytoskeletal arrays, especially
those associated with the plasma membrane. These alterations result
junctional leakage and cell injury (7, 14, 38, 70).
One or more viral proteins may cause cytoskeletal alterations. Nef (Negative
Factor) is a regulatory protein that leads to a loss of actin stress fibers,
increases lamellipodia and causes HIV-associated nephropathy (36). The
regulatory protein Tat down-regulates the expression of several cytoskeletal
proteins including tubulin (9). Tat causes a decrease in microtubule-associated
protein 2 (MAP2) and the collapse of neuronal cytoskeletal filaments in
biopsies of patients exhibiting HIV-induced encephalopathy (1). Tat
expression in lymphoid cells shortens microtubules (MTs) and leads to
apoptosis (26). In vitro experiments however show that Tat can stimulate MT
polymerization (26). Watts et al. suggest that some cytoskeletal defects seen
in HIV-infected cells might be caused by the regulatory protein Rev as Rev
binds tubulin and depolymerizes MTs in vitro (65). Over-expression of Rev
impairs cell cycle progression leading to defects in mitosis (43) suggesting
that Rev-MT interactions may be important.
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Microtubule Dynamics
MTs are an important component of the cytoskeleton and play crucial roles in
the development and maintenance of cell shape, cellular transport and cell
division. They are polymers of α- and β-tubulin heterodimers. Heterodimers
assemble into linear protofilaments that laterally associate with each other to
form hollow tubules. MTs have an intrinsic ability to spontaneously grow and
shrink. One end, denoted as the (+) end and terminating with β-tubulin, is
more dynamic than the (-) end. Plus end polymer growth and shrinkage rates
are several-fold faster than at the opposite end. Whether a MT will grow or
shrink depends on two factors: the guanine nucleotide bound state of the β
subunit and the concentration of free heterodimers available for
polymerization.
Both a- and β-tubulin are GTPases. However, a-tubulin is always bound to
GTP (or GDP•Pi) owing to the structure of the heterodimer (33). The
nucleotide-bound state of the β subunits is key. When heterodimers newly
incorporate into a MT polymer, they activate GTP hydrolysis in underlying β
subunits. Consequently, β-tubulin may be bound to either GTP or GDP.
When β-tubulin is bound to GTP, tubulin heterodimers assume a ‘straight’
conformation allowing it to incorporate at MT ends and associate laterally
with adjacent protofilaments. In the GDP-bound state β-tubulin assumes a
more curved conformation that cannot be incorporated into MT ends. The
majority of β-tubulin within the body of a MT is bound to GDP owing to its
GTPase activity.

However, it is constrained to lie ‘straight’ due to its

interactions with adjacent protofilaments. Essentially, MTs are tensioned and
primed to disassemble, held intact only by the β-tubulin•GTP cap that forms
at the MT end. Loss of the ‘GTP cap’ exposes β-tublin•GDP that leads to
2

depolymerization. The concentration of heterodimers available for
polymerization also determines whether MTs will grow or shrink. The critical
concentration (Cc) is that concentration of free heterodimer where rates of
growth and shrinkage are equal at both ends of MT. When the concentration
of α-/β-tubulin is greater than Cc, growth occurs.
Although purified MTs will exhibit spontaneous growth and shrinkage in
vitro, anti-mitotic drugs like Taxol, maytansine and colchicine are effective
because they affect the nucleotide-bound state of β-tubulin, the conformation
of the heterodimer, or the concentration of soluble heterodimers. Taxol
(paclitaxel) promotes polymer assembly (6). It has a high affinity for tubulin
(Kd = 10–8M) and binds two patches in a nucleotide-sensitive helix of βtubulin (19, 29). Its binding enhances MT polymerization by binding βtubulin on the inside of the MT where it stabilizes interactions between
adjacent subunits (45).
On the other hand, maytansine, vinca alkaloids and colchicine depolymerize
MTs. Vinca alkaloids and maytansine disassemble MTs by binding tubulin
polymers (8) at or near the nucleotide-binding site of β-tubulin (53). MTs
treated with vinca drugs depolymerize forming spiraling protofilaments and
other curved MT structures. At higher concentrations, vinca alkaloids inhibit
MT polymerization (28).
Colchicine depolymerizes MTs by a different mechanism. It binds at the
interface of α and β subunits and is not inhibited by Taxol and only marginally
inhibited by maytansine (8). It depolymerizes MT in two different
mechanisms. First, it binds to soluble tubulin and reduces the concentration
of tubulin heterodimers available for polymerization. This shifts the
3

equilibrium away from polymerization and towards depolymerization (4).
Second, it binds to tubulin heterodimers and forms tubulin-colchicine
complexes, which incorporate at the MT ends (28). When concentration of
colchicine-tubulin dimers is more than free tubulin, it binds to MT end and
prevents the further addition of other free tubulin subunits at the end of a MT.
Thus it poisons MT ends.
Temperature

also

affects

the

polymerization

state

of

MTs.

At

unphysiologically cold temperatures, MTs depolymerize releasing tubulin
heterodimers and curved oligomers and rings (42). Warmer and physiological
temperatures promote polymerization (in presence of GTP) (33). Obviously
cells do not regulate MT dynamics by regulating cell temperature. They rely
on cellular proteins called MT-associated proteins (MAPs). Some MAPs like
Tau and Map2 are important for stabilization of MT. These MAPs causes
cross-linking of protofilaments and formation of bundles of microtubules via
their N-terminal projection domain results into stabilization of MT (13). Other
proteins including some kinesins promote depolymerization. Kinesins are
motor proteins involved in most MT activities and are essential for spindle
function during cell division.
One well-studied kinesin is xMCAK, a member of the Kin13 family of motor
proteins distinguished from motile kinesins by their ability to depolymerize
MTs. Its depletion in the Xenopus egg extracts in presence of chromatin
suppresses the bipolar spindle formation and results in abnormally large MTs
(15, 59, 62, 65). Conversely, addition of xMCAK can completely suppress
MT formation. xMCAK does not act as a conventional motor protein that
translocates along microtubules. Instead it diffuses along the microtubule
lattice targeting the ends of the microtubules and causes depolymerization
4

(23). During depolymerization, it induces a conformational change in the
microtubule resulting in protofilament peeling similar to the conformation
change when GTP of β-tubulin undergoes hydrolysis. This leads to the release
of many tubulin dimers and a small number of tubulin dimer/xMCAK
complexes (63). xMCAK consist of three domains. An N-terminal domain
targets xMCAK to kinetochores. A middle motor domain and neck region are
essential for depolymerization. The C-terminal tail is essential for tight MT
binding in the presence of excess tubulin heterodimer and regulates
homodimerization and influences ATPase activity (40, 46, 21).
The mechanism by which xMCAK depolymerizes MTs is well understood.
Only the motor domain and neck are required for depolymerization. The neck
is positively charged and binds to the acidic C-terminus of tubulin. It makes
MT depolymerization more efficient by disturbing lateral interactions
between the MT protofilaments at MT ends (40, 46, 21). The α4 helix of the
motor domain of the murine ortholog of xMCAK Kif-2C binds to the curved
MT end and links the poly-glutamate tail of β-tubulin with α-tubulin (46). This
crosslinking of the poly-glutamate tails stabilizes the curved structure of the
intradimer interface and causes the initiation of ATP hydrolysis. Crosslinking
also facilitates the insertion of a KVD finger (Lys293Val294Asp295-absent
in motile kinesins) in the interdimer interface and stabilizes the curved
conformation of the protofilament. Therefore the α4 helix is thought to
stabilize the curved conformation of MT ends. Moreover, mutation of KVD
and KEC (Lys268Glu269Cys270) residues of the α4 helix inhibits xMCAK’s
ability to depolymerize MTs (46, 56). In this way, xMCAK specifically binds
to the ends of MTs and stabilizes an already bent conformation or induces a
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curvature at the MT end (15, 46, 21, 56). This curved protofilament within the
MT is unstable and is thought to cause the MT polymer to depolymerize (62).

Rev
Rev function
Rev is 13 kDa basic protein with high affinity for RNA (11, 20, 67, 70). It is
produced early in infection and is essential for late stages of viral infection.
During the early phase, the provirus integrates into the host genome where it
transcribes a 9 kb primary transcript. This 9 kb mRNA can be spliced into the
various classes of transcripts: fully spliced 2kb transcripts, 4kb transcripts
containing one intron, and 9kb unspliced transcripts containing two introns.
Of these three transcripts, only the 2kb mRNAs are exported into the
cytoplasm where they translated into one of three proteins, one of which is
Rev.
Rev enters into the nucleus in a NLS-dependent fashion (70). The NLS
(nuclear localization signal) contains an arginine-rich motif with sequence
30

TRQARRNRRRRWRERQR50. Mutating this sequence (M6: 41RRRR→DL

and M5: 38RR→DL), results into a significant level of Rev accumulation in
the cytoplasm (65). Cytoplasmic accumulation is not absolute as Rev is small
enough to diffuse into the nucleus. The NLS binds importin β, a cytoplasmic
importing receptor and Ran•GDP docks Rev to nuclear pore complexes (57).
The exchange of GDP for GTP releases Rev from the importin β-pore
complex allowing import into the nucleus. Nuclear exchange occurs because
RCC1, Ran’s nucleotide exchange factor, is bound to the chromatin (44, 47).
Conversely, the Ran•GAP (RanGTPase activating protein) is localized in the
cytoplasm ensuring hydrolysis of GTP so that Ran is bound to GDP in
6

cytoplasm (51). This gradient of Ran•nucleotide, Ran•GTP in the nucleus and
Ran•GDP in the cytoplasm, ensures the directionality of Rev transport.
As Rev expression level rises during the early phase of infection, it promotes
the gene expression of late phase proteins like gag, pol, env, vif and vpr
without activating transcription (65). In the nucleus, Rev binds to the Rev
Response Element (RRE), ≈351 nucleotide sequence present in the 3’ intron
of 4kb and 9kb transcripts. The RRE forms the intramolecular double stranded
stems and single stranded loops. Rev multimerizes on the RRE by the
arginine-rich motif (ARM, amino acids 37-50) that overlaps with the NLS.
Rev-RRE binding triggers RNA export although binding of a single-Rev
monomer is insufficient to export of transcripts-multimerization at least four
Rev monomers is essential (11, 70).
The ability to multimerize on the RRE is mediated by amino acid sequences
9-26 and 51-65 that straddle the arginine rich motif. Rev-RRE multimers are
then exported into the cytoplasm owing to the nuclear export sequence (NES)
(51). Mutation of 9-26 and 61-65 residues impairs multimerization and
reduces Rev affinity for the RRE, resulting in inhibition of formation of high
molecular weight complexes on the RRE (16).
The NES is present near the C-terminus, amino acids 75-83. It is rich in
leucine residues. The export factor Crm1 and Ran-GTP bind to the NES and
the newly formed complex consisting of Rev-RRE, Crm1, Ran-GTP is
targeted to NPCs (60). The complex is disrupted by the GTP hydrolysis
stimulated by cytoplasmic RanGAP. The released RRE-containing transcript
is then engaged by ribosomes and late viral proteins are expressed. Mutation
in its NES inhibits Rev’s ability to bind export factor Crm1 (51). The M10
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(78LE→DL) mutant Rev localizes almost exclusively in nucleoli due to
defective nuclear export.
Unliganded Rev re-enters the nucleus by using NLS (37). Once Rev is back
inside the nucleus, it is again ready for export of other intron containing
transcripts. Therefore Rev Protein is important for the nuclear export of
intron-containing transcripts.

Rev interactions with MTs
While attempting to determine the three-dimensional structure of Rev, Watts
et al. found that Rev interacts with tubulin (65). When highly purified Rev is
mixed with MTs, MTs rapidly depolymerize forming rings they called Revtubulin toroidal complexes (RTTs). RTTs are 3-4 MDa, double-ringed
structures with 28, 30 or 32 Rev-tubulin dimers (65). RTTs are similar to
rings when MTs depolymerized by cold (39, 42, 65) or exposed to certain
antineoplastic drugs belonging to the maytansine family of anti-mitotics,
Dolstatin-10, cryptophycin, hemiasterlin (2, 3, 65). These drugs with great
anti-cancer potentials have ability to produce curved tubulin structures e.g.,
rings, spirals, and bracelets (2, 15, 22, 29, 65). Curved tubulin structures are
thought to be important events that initiate depolymerization (12, 15, 22).
Therefore formation of rings of tubulin by Rev in vitro suggests that Rev may
affect the polymerization state of MT in cells during HIV infection.

Watts et al. (65) predicted that Rev and tubulin interacts via simple
electrostatic interactions: Rev is a basic protein (pI = 9.2) and possesses an
arginine-rich region whereas tubulin is acidic (pI = 4.8-5.2) and both α- and
β-tubulin have glutamate-rich C-terminal tails. RTTs and/or Rev-tubulin
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complexes, however, still form under experimental conditions that abrogate
simple acid:base interactions e.g., presence of salt, changes in pH, and
removal of tubulin tails by subtilisin. This shows that Rev-tubulin interactions
are more complex than simple charge interactions. Rev-tubulin interactions
require Mg2+. RTTs formed when Rev is mixed with either taxol-stabilized
MTs and colchicine-depolymerized tubulin. Maytansine however inhibits
RTT formation suggesting that Rev binds at or near the vinca site of β-tubulin.
Collectively these data suggests the interaction between Rev and tubulin or
MTs is specific.
Watts et al. looked for sequence similarities between Rev and other MT
depolymerizing proteins. A statistically significant similarity exists between
Rev’s ARM (amino acids 34-70) and the motor domain of xMCAK (amino
acids 506-543). Rev’s ARM amino acids E57, R42, and R50 are similar to the
amino acids in α4 helix of the motor domain of xMCAK. In vivo, mutants of
these amino acids appeared to have the corrected mitotic defects which was
not seen in wild type Rev expressing cells. Therefore by considering the
similarities between Rev’s ARM and xMCAK motor region, the ARM may
act like the xMCAK α4 helix that binds the tubulin intradimer interface. There
are additional similarities between Rev- and xMCAK-mediated MT
depolymerization. Both Rev and xMCAK cause depolymerization from both
ends of MTs (15, 65). Neither xMCAK nor Rev require ATP hydrolysis for
depolymerization, although xMCAK relies on ATP hydrolysis to release
tubulin heterodimer thus allowing the enzyme to recycle for another round of
depolymerization. xMCAK-mediated depolymerization is more efficient than
that mediated by Rev as Rev lacks a recycling mechanism (15, 65).
Depolymerization of stabilized MTs by both proteins results into tubulin rings
9

(15, 65). It is possible that multimerization of Rev occurs at the tubulin
intradimer interface as ATP state does for xMCAK. Taken together, these data
suggest that Rev might multimerizes and induces the curved conformation of
MT ends similar to xMCAK. Also both proteins affect the cell cycle
progression. Kin13 alters spindle assembly and chromosomal movement (62),
whereas overexpression of Rev accumulates the cells in prophase and
metaphase (27, 43). Therefore Rev may be a useful model for understanding
how MCAK depolymerizes MTs.

Rev-tubulin interactions in vivo:
Previous data show that Rev has the potential to affect the cell cycle
progression by affecting spindle function through its ability to bind tubulin
and depolymerize MTs. Rev inhibits aster formation in frog egg extracts that
recapitulate the multiple cell cycles in vitro showing that Rev and tubulin can
interact in the presence of cellular constituents (14, 65). Transient overexpression of Rev expressing COS and Hela cells slows cell growth (43, 27).
Rev expression leads to chromosomal abnormalities and accumulation of cells
in G2/M specifically before the spindle checkpoint (27, 43). These defects
may result from Rev’s ability to alter spindle dynamics by depolymerizing
MTs, interfering with MT polymerization by sequestering tubulin
heterodimers, or interfering with centrosome duplication (43). Its overexpression can produce changes in ploidy. Cells divided into more than the
normal number of daughter cells where MTs are shared between the three
forming daughter cells (27). The nuclei of these cells were abnormally larger
and the MT cytoskeleton was highly perturbed (27).
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To test the hypothesis that Rev depolymerizes microtubules in living cells
leading to growth defects, the rates MT arrays recover after depolymerization
in the presence and absence of Rev were measured. If Rev expression
promotes MT depolymerization, either by active depolymerization or by
tubulin sequestration, then recovery should be slower in Rev cell lines than
control lines.
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Materials and Methods
Cell culture:
HeLa cells were maintained at 37˚C in Dulbecco’s Modified Eagle medium
with high glucose supplemented with 10% Fetal Bovine Serum (FBS), 100
µg/L streptomycin, and in the humidified incubator with 5% CO2. Cells were
grown in 100 mm x 20 mm polystyrene cell culture dishes. When growth was
confluent, cells were passaged into new cultures by treatment with 0.25% of
trypsin with 0.5 mM EDTA. Briefly, media was removed and cells were
washed with PBS (Phosphate Buffered Saline-137 mM NaCl, 2.7 mM
KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4). 1 mL of 0.25% of trypsin with
0.5 mM EDTA was added for 2 minutes at 37o C. Trypsin activity was
quenched with the addition of 9 mL of media. New 10 mL cultures were
seeded with 1 ml of cells liberated by trypsin-EDTA treatment. HeLa cells
stably expressing YFP, Rev-YFP, M6-YFP, M4-YFP and Rev-GR-GFP (2.2)
were also maintained for further study.

Plasmid Isolation:
YFP-C and YFP-Rev plasmid containing E. coli (DH5α) were grown in
LB/Amp broth overnight. Bacteria were then plated on LB/Amp plates and
individual colonies were used to inoculate LB/Amp broth cultures. After 1824 hour of growth, bacteria were collected by centrifugation at 5000 x G for
15 min at 4oC. Plasmids were isolated by using QIAfilter Mini Kit (Qiagen)
as per manufacture’s instruction.

Transfection:
Prior to transfection HeLa cells were grown in 6 well plates. After 50%
growth, cells were transfected with 1.6μg of YFP-Rev and YFP-control, by
12

using Polyfect transfection reagent (Qiagen). Cells were incubated for 24
hours for transient expression of YFP and Rev-YFP.

Cold depolymerization and recovery of MTs
To compare the recovery of MTs in Rev and YFP expressing cells,
‘trypsinized cells’ were seeded onto poly-L-lysine coated coverslips in 1 mL
media per well in a six well plate. When cells were 70-80% confluent, the
media was removed and replaced with ice-cold L-15 media. Cells were
maintained in an ice-cold water bath for three hours.
To induce MT recovery, cold media was removed and replaced with warm L15 media and incubated at 37˚C with 5% CO2. At different times, cells were
fixed with freshly made 4% paraformaldehyde dissolved in PBS for 90 m.

Colchicine Depolymerization
Cells were grown on coverslips placed in 6-well dishes. After cultures were
70-80% confluent, cells were used for colchicine depolymerization of MT.
100 mM Stock colchicine was prepared in ethanol and stored at 4°C.
Colchicine was freshly diluted 1000-fold from 100 mM ethanol stock in warm
DMEM. 2 ml of 100 nM Colchicine was added in each well and plate was
incubated at 37°C for 15 m. Cells were rinsed twice with warm media to
remove bound and excessive colchicine and then incubated in warm media for
3, 6, 12 and 24 hours.

At these time points cells were fixed in

paraformaldehyde.
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Immunofluorescence Microscopy
Fixed cells were washed with PBS for four times and then permeabilized by
5 m treatment with 0.1% Triton X-100-PBS. Cells were washed four times
with PBS and transferred to blocking buffer (2% BSA and 0.1% NaN3 in 50ml
of PBS) for 30 minutes. After additional washed with PBS, tubulin-specific
antibody (DM1α) diluted (1:500) in blocking buffer was added for 1 hour at
room temperature. Excess antibody was washed away by six washes with
PBS. To detect MT-DMA1α complexes, goat anti-mouse IgG conjugated to
Texas Red diluted (1:500) in blocking buffer was added to cells and incubated
an additional hour at room temperature. Excess antibody was removed by
dilution with six PBS washes. Coverslips were mounted on glass slide by
using DAPI and PPD fluorescence mounting media. Images were then
analyzed and processed using the Metamorph software program (Metamorph
Meta Imaging Series 6.1).

Quantifying MT Recovery After Depolymerization
MT recovery was quantified by two methods: visual array index (VAI) and
microtubules array assay (MAA). In the former method, two independent
judges scored images of randomly selected cells in a blinded manner. The
extent of recovery was scored using the rubric outlined in Figure 1. At least
twenty random cells were scored and scores were averaged for each time
point. To determine the statistical difference if one exists, a Ranked order
analysis, Rfit, was performed comparing time, sample, and trial. Statistically
significant results were subjected to paired t-test with Bonferroni corrections.
The MAA method measured the area within a cell covered by MTs. Twenty
cells from randomly chosen fields of viewed were quantified using ImageJ
software. To locate the boundaries of MTs easily, images were converted into
14

gray scale and converted to a binary image using the staining intensity of MTs
to set the threshold gray value. ImageJ was used to measure the area of MT
fluorescence. The MT area of 20 cells was averaged per time point. There
were three independent trials. To determine the statistical difference if one
exists, a multiple ANOVA was performed comparing time, sample, and trial.
Statistically significant results were subjected to paired t-test with Bonferroni
correction. The triplicate samples of each time point was averaged and
separate graphs were plotted for Rev-YFP, M6, and M4 with their control.
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Figure 1: Estimating MT recovery by determining a Visual Array Index.
Cells are scored from 0 to 4 depending on phenotype of MT arrays. A.
Cytoplasmic microtubules are depolymerized with no intact MTs. Most
tubulin is present as dots of fluorescence. B. Cells have small asters with few,
short MTs. C. Asters are small with MTs roughly spanning the radius of a cell.
It is impossible to manually count MTs. D. MTs are shorter than untreated
cells but cover roughly 50% of normal arrays. E. MTs cover most of the
cytoplasm but arrays are not as extensive as untreated cells. F. Cells possess
large population of long MTs extending to the periphery. Bar = 5µm.
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Results
To test the hypothesis that Rev depolymerizes microtubules in living cells,
one would ideally measure MT dynamics in living cells expressing Rev or a
control protein. This is difficult due to the overwhelmingly large number of
MTs present. However measuring the dynamics of individual MTs at the cell
periphery using time-lapse video microscopy is a common solution. Before
committing to such laborious methodology, bulk MT dynamics can be
estimated by monitoring the ability of MT arrays to recover from cold-induced
depolymerization. Consequently HeLa cells transiently expressing YFP and
Rev were placed on ice to depolymerize MTs. Unfortunately, after cold
treatment cells were not viable. Therefore, Hela cells stably expressing YFP
and Rev were used. Since HeLa cells do possess cold-stable MTs (33), all
MTs are depolymerized by this treatment (Figure. 1A). Cells were then
allowed to recover different times at 37˚C before fixed and the extent of
recovery was quantified using two assays as described in the “Materials and
Methods.” If Rev depolymerizes MTs, then MT recovery should be slower in
cells expressing Rev.

Microtubule recovery in Rev expressing cells
Two assays were used to estimate recovery. The first calculates a Visual
Array Index (VAI) score, a qualitative assessment of recovery. Cells are given
a score of 0-4 depending on extent of MT polymerization and cytoplasmic
coverage using a rubric listed in figure 1.
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Figure 2: Cellular localization of Rev. Photomicrographs of cells expressing
YFP (A), Rev-YFP (B), RevM6-YFP (C), RevM4-YFP (D), and Rev2.2 (E)
Bar = 5µm.
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Figure 3 shows the representative images of fluorescence in YFP and RevYFP expressing cells at different times of recovery. MT arrays in both control
and experimental cells recover as function of time. After three hours of cold
treatment, MT depolymerization was essentially complete in Rev and YFP
controls (Fig.3 A, B). This is consistent with published research (42). After 5
m of recovery, YFP cells show average VAIt5 of 0.8, the VAI t5 of Rev cells
is 0.9 (Fig. 3 panel C, D). After 15 m recovery, MTs in both YFP and Rev
expressing cells are short segments covering rough half of the cytoplasmic
area (VAI=2.4) (Fig. 3 E, F). At later time points, there was extensive MT
recovery in both cell types (YFP VAIt30=2.9, Rev VAIt30= 2.8, and YFP
VAIt60=2.9 and Rev VAIt60=2.6). MT recovery was time-dependent
(p<0.001). There is no statistically significant difference between the recovery
rates in YFP and Rev expressing cells (p>0.05). To avoid biased scoring, the
same photomicrographs were re-scored by a second, blinded analyst. The
results obtained by the second analyst confirmed the original data set (data not
shown). Analysis of two scoring by Rfit model showed that Rev expressing
cells does not inhibit MT recovery.
Given the intrinsic qualitative nature of VAI scoring, MT recovery was also
measured using an assay less prone to subjective error. The MT Area assay
attempts to measure the surface area covered by fluorescently labeled MTs.
The areas of MT at different stages of recovery are shown in Appendix 1. MT
recovery was time-dependent (p<0.001). However analysis of data by
multiple ANOVA showed that there was no statistical significant difference
between experimental and control cells. Together with VAI data, these
observations are collectively inconsistent with hypothesis that Rev expression
inhibits the recovery of MT arrays following depolymerization.
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Figure 3: YFP and Rev expressing cells have similar MT recovery rates.
The average VAI for cells immunolabeled with anti-α tubulin antibody are
listed at right bottom of each panel. A and B: cells show complete
depolymerization of MTs after three hours of cold treatment (0’). MTs start
to polymerize at 5’ time point (C and D). In subsequent time points such as
15’ (E and F), 30’ (G and H), and 60’ (I and J), both Rev expressing and
control cells show same increase in MTs. Bar = 5µm.
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Figure 4: MT Area Assay. MT surface areas in Rev and YFP expressing
cells recovering from cold treatment are similar. Cells are immunolabeled
as above. Twenty cells were threshold and MT area was measured by using
ImageJ computation method. Graph demonstrates the average of MT area
(Appendix 1) of three trials on Y- axis and time of recovery on x-axis. The
error bars represent standard deviation. Rev and YFP expressing cells show
similar recovery after cold depolymerization at each time of recovery
(P>0.05).
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MT recovery in Rev mutants:
One possible reason why Rev does not demonstrably affect rates of MT
recovery may be due to an insufficient concentration of Rev in the cytosol. In
Rev expressing cells, Rev primarily localizes to the nucleus with substantial
localization in interphase nucleoli. Since tubulin exclusively localizes to the
cytoplasm, there is limited opportunity for Rev and tubulin to interact during
interphase. To increase the cytoplasmic concentration of Rev, Rev mutants
M4, M6 and 2.2 were also studied.
M6 is a mutation in the NLS that inhibits Ran-dependent nuclear import of
Rev in the nucleus (58). In contrast to wild-type Rev, M6 localizes equally in
the cytoplasm and nucleus since Rev has an ability to diffuse into nucleus
(Figure 2). M4, possessing a mutation that blocks homo-multimerization,
predominately localizes to cytoplasm with reduced amounts in nucleolus
(Figure 2). Both M6 and M4 have the ability to bind tubulin heterodimers in
vitro (54). Moreover, transient and stable over-expression of M6 and M4 in
HeLa cells leads to defects in cell cycle progression (55). Neither mutant are
able to depolymerize MTs in vitro so if they are to have an effect in recovery
assays, they are predicted to slow recovery by decreasing the concentration of
tubulin available for polymerization.
The Rev2.2 HeLa cell line stably over-expresses Rev fused to the hormoneresponsive element of the glucocorticoid receptor and GFP (34). In the
absence of hormone, Rev2.2 protein localizes exclusively in the cytoplasm.
Previous results show that Rev2.2 cells spend more time in mitosis similar to
cells expressing Rev (41). Whether Rev2.2 retains the ability to depolymerize
MTs in vitro is not known. Depending on these observations, it was
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hypothesized that RevM6, RevM4 and Rev2.2 may show slower
polymerization compared to control cells.

RevM6 and control cells show similar rates of recovery after microtubule
depolymerization by cold
Figure 5 shows representative results comparing the recovery of MT arrays in
RevM6 and YFP expressing cells. After depolymerization, control and M6
VAI values were 0.2 and 0.1, respectively. Later time points both RevM6 and
control cells showed similar score. Rank order analysis of this scoring
suggested that the rates of recovery in RevM6 and control cells were
statistically similar to controls (p>0.05). Whereas blinded scoring
demonstrated that RevM6 cells has faster recovery than control cells. Similar
conflicting results were obtained during statistical analysis of MAA data,
where point to point t-test showed that there was no difference in recovery
whereas multiple ANOVA suggested that RevM6 cells has faster recovery
than control cells (Figure 6). Comparable results of both VAA and MAA
suggest that RevM6 does not inhibit the MT recovery.
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Figure 5: RevM6 and control cells show similar rates of recovery after
microtubule depolymerization by cold. Cells are immunolabeled with antiDMA-1α antibody to visualize microtubules. Right bottom shows the average
score of 20 cells of three trials. Similar to Rev expressing cells, RevM6 and
YFP show no remarkable difference in recovery of MTs after
depolymerization. Both RevM6 and YFP also show similar time dependent
increase in polymerization of MTs during recovery periods (p<0.001). Bar =
5µm.
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Figure 6: MT Area Assay. RevM6 and control cells show similar growth
of microtubule. Twenty cells were threshold and MT was measured by using
ImageJ. Graph demonstrates the average of MT area of three trials (Appendix
2) with the error bars of standard deviations. RevM6 and YFP expressing cells
show similar MT area in successive time of recovery.
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RevM4 and control cells show similar recovery after microtubule
depolymerization by cold
The recovery of MTs arrays after depolymerization in RevM4 and YFP
expressing cells at different times is shown in Figure 7 and 8. MT arrays
recover

at

similar rates

in

RevM4 and

YFP expressing

cells.

Depolymerization was not as effective in these experiments as small aster-like
structures were visible (YFP VAIt0=0.0, RevM4 VAIt0=0.2) (Fig. 7A, B).
After 5 m of polymerization, YFP cells had growth of MTs segments
originating at the centrosome (VAIt5= 0.8). M4 expressing cells often had
short MT arrays not connected to the centrosome (VAIt5= 1.4). At later time
points, most of YFP and RevM4 cells’ MTs appear like score “3” where most
of microtubules segments are scattered in the cytoplasm (YFP VAIt15=2.4,
RevM4 VAIt15= 2.6, YFP and RevM4 VAIt30/60=2.8) (Figure. 7).
Measurement of MT areas showed that recovery was similar in M4 and
control cells (p>0.05) by point-to-point t-test (Figure 8). Further analysis
of this data showed similar results with Rev-M6.
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Figure 7: RevM4 and control cells show similar recovery after
microtubule depolymerization by cold. Cells are immunolabeled and
visualized for microtubule presence. Right bottom shows the average score of
20 cells of three trials. After cold depolymerization RevM4 and control cells
show the absence of MT arrays (0’). With successive increase in recovery
time both cells show same rate of MT polymerization at each time points
(p>0.05). Bar = 5µm
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Figure 8: MT Area Assay. RevM4 mutant show polymerization of MTs
similar to YFP. Graph demonstrates MT area average of YFP and RevM4
expressing cells of three trials at different recovery time (Appendix 3).
Standard deviation (Appendix 3) is plotted as error bars at different time
points. RevM4 and YFP expressing cells show similar increase in MT
presence at consecutive time (p<0.05). Both RevM4 and control cells show
similar increase in MT area.
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Rev2.2 expressing cells show insignificant difference in recovery of
microtubules compared to control cells
The recovery of MT arrays in Rev2.2 and control cells is shown in Figure 9.
The extent of MT depolymerization is similar in both cells, VAI=0.0.
Nucleation of MTs was evident after 5 m in both cells (VAIt5= 0.7). Recovery
continued over the course of the next hour. During the 60 m of recovery, MTs
become long and covered 50% of area of cell (YFP VAIt15= 2.3, Re2.2= 2.2,
YFP VAIt30=2.7 and Rev2.2 VAIt30= 2.3). At 60 m, YFP expressing cells show
MT presence similar to that of 30 m recovered YFP cells (YFP VAIt60=2.7).
On other hand, at 60 m Rev2.2 showed average score “3.4” where most of the
MTs are formed and present in bundles. VAI show that there is no effect of
Rev polymerization of MTs. Microtubule area measurement showed that
Rev2.2 expressing cells do not recover slowly compared control cells (Fig.
10). These data are consistent similar to those obtained when cells expressing
RevM6 and RevM4 were used.
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Figure 9: Rev2.2 and control cells show similar recovery after
microtubule depolymerization by cold despite high levels of Rev in the
cytoplasm. Rev2.2 cells express Rev, fused to the glucocorticoid
receptor in the absence of hormone. Visual Array Assay. At different time
points both cells show very similar recovery of MTs (A-J). Bar = 5µm.
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Figure 10: MT Area Assay. Rev2.2 mutant show polymerization of MTs
similar to YFP. MT Array Area Assay. Graph shows the average MT area
versus time of recovery of single trial when Rev2.2 and YFP cell’s MTs were
depolymerized and recovered. Rev2.2 and YFP expressing cells show similar
increase in MT presence at respective time points.
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MT recovery in Rev expressing metaphase cells
During metaphase, Rev localizes around the periphery of chromosomes where
MTs that comprise the spindle apparatus are known to nucleate owing to the
Ran-GTP gradient (27) (Figure 11). This suggests that Rev is temporally and
spatially positioned to perturb the mitotic spindle. Since Rev expressing cells
show slow cell cycle progression spending more time in metaphase (27, 43),
it seems possible Rev-MT interactions are important during division. To test
this, I measured MT arrays in mitotic cells after cold treatment. Only cells in
metaphase were included in this study. MTs of Rev and YFP expressing
metaphase cells were depolymerized by cold. At t=0 m, cells had
chromosomes aligned at the metaphase plate but no MTs were present (Figure
12). After 60 m of recovery, defects were evident in both cells. Unaligned
chromosomes (Figure 13, 14) and tripolar spindles (Figure 13, 14C) were
common. However, the number of abnormalities seen in both cells was
similar suggesting that Rev was not the cause of these abnormalities.
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Figure 11: YFP and Rev expressing metaphase cells. YFP (A) and Rev (B)
expressing metaphase cells were immunolabeled with tubulin specific
antibody and DNA was stained with DAPI. Each of the panels (Left to right)
displays DAPI, tubulin, YFP and merge channel that shows the spindle
formation around the chromosome. Bar = 5µm.
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Figure 12: YFP (A) and Rev (B) expressing Metaphase cell after cold
depolymerization of spindle. YFP expressing Hela mitotic cells were
depolymerized on ice cold water for three hours, immunolabeled with tubulin
specific antibody, and DNA was stained with DAPI. Each of the panels (Left
to right) displays DAPI, tubulin, YFP and merge channel. Merge panel shows
the depolymerized spindle around the chromosome. Bar = 5µm.
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Figure 13: YFP expressing Metaphase cells show chromosomal and
spindle formation abnormalities after recovery. YFP expressing mitotic
cells were depolymerized on ice cold water for three hours followed by
recovery of spindle for 60 minutes at 370c. Cells were immunolabeled with
tubulin specific antibody and DNA was stained with DAPI. All panels display
depicts the merge channel of the depolymerized spindle around the
chromosome. Metaphase cells show lost chromosomes (A-F) with normal
spindle formation after recovery of 60 minutes. Bar = 5µm.
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Figure 14: Rev expressing Metaphase cells show chromosomal and
spindle formation abnormalities similar to YFP expressing cells after
recovery. Similar to YFP expressing metaphase cells, Rev expressing mitotic
cells were depolymerized on ice cold water and spindles were recovered. Cells
were immunolabeled with tubulin specific antibody and DNA was stained
with DAPI. Rev expressing cells showed chromosomal and spindle
abnormalities similar to YFP expressing cells (A-D). Bar = 5µm.
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Discussion
Previous data clearly shows that Rev binds tubulin and depolymerizes MTs in
vitro (65). That Rev inhibits aster formation in Xenopus egg extracts shows it
has the potential to perturb MT dynamics under cell-like conditions. Such
dramatic inhibition occurs only when Rev and tubulin concentrations are
equal, a condition unlikely to exist in living or transformed cells. However,
low levels of Rev may be sufficient to poison MT dynamics at the plus-ends
to generate more subtle and potentially lethal effects (65). Certainly, many
anti-mitotic drugs that obliterate MT arrays at high concentrations are lethal
at concentrations 1000-fold less because they subtly alter MT and or spindle
dynamics. The cell cycle defects seen in Rev-expressing cells are consistent
with this hypothesis (27, 43).
This study aims to determine whether Rev has the ability to depolymerize
MTs or otherwise affect their activity in living cells. Data presented here
shows that over-expressing Rev does not inhibit recovery of MT arrays
following depolymerization in interphase cells. These data are consistent with
experiments using egg extracts–the cellular concentration of Rev is
insufficient to elicit a detectable effect. It is important to recognize that the
assays used in this study monitored bulk MT dynamics and may not be
sufficiently sensitive to detect subtle effects. Future experiments should use
time-lapse video microscopy to track the dynamics of individual MT
dynamics measuring rates of catastrophe and rescue.
On the other hand, Rev might have subtle affects on MT that are visible only
when following the complex movements driven the mitotic spindles. This is
reminiscent of the action of anti-mitotic anti-cancer drugs. Moreover, Rev
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localizes perichromosomally in metaphase cells so it is well positioned to
affect MT behavior at the kinetochore. To this end, the ability of MTs to
recovery after cold-treatment in Rev expressing cells was studied. Indeed,
there are obvious defects in Rev expressing cells (Fig.13 & 14). Fewer but
similar defects were observed in control cells suggesting there was no
consequence attributable to Rev. Future work should repeat these experiments
increasing sample sizes. Moreover, imaging of living mitotic cells would be
useful to accurately track chromosomal movements and spindle activity.
With the exception of possible effects that occur during cell division, the
results of these experiments suggest that the cell cycle defects seen in Rev
expressing cells is not directly due to Rev:tubulin/MT interactions. How then
is Rev affecting cell growth? Rev may affect the cell cycle progression
through its interactions with B23 or Ran. Normally, B23 is present in nucleoli;
however, in Rev expressing cells, B23 colocalizes with Rev in the cytoplasm
as well as nucleoli (27). Moreover, nucleolar morphology is abnormal when
levels of Rev expression are high. As B23 is important in assembly and
maturation of ribosomes, it is possible that Rev is inhibiting B23 function
reducing the ribosome synthesis and reducing levels of protein synthesis. This
is consistent with the observation that Rev expression slows all stages of the
cell division cycle (27). To test this hypothesis, future experiments should
attempt to measure the rates of ribosome synthesis and protein synthesis in
Rev expressing and control cells. In addition, mutations in Rev and/or B23
that block Rev-B23 interactions should restored cellular growth rates.
Given that Rev interactions with Ran in nuclear export and import, Rev may
alternatively be altering cell growth through its interactions with Ran. Ran is
a small GTPase, important in nucleocytoplasmic transport of many proteins
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and RNAs (18, 57). It is also important for microtubule nucleation (18, 57).
Consequently Ran affects transport of proteins and RNAs important for cell
proliferation and differentiation and regulates the structure and function of the
mitotic spindle (52). It is significant that Rev concentrates around the
periphery of metaphase chromosomes where Ran•GTP accumulates (57).
Thus, Rev is positioned to both destabilize kinetochore MTs and affect the
function of Ran•GTP. Future experiments should therefore attempt to follow
Rev:Ran interactions, particularly during mitosis. Live cell microscopy in
Rev expressing mitotic cells should be instructive.
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Appendices
Table 1: YFP-C and Rev-YFP

YFP

Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

38969

38244

43895

403693075

5

34113

48395

42320

416097167

15

38073

56894

50249

484059545

30

35716

61237

57909

5162113874

60

60941

66363

74852

673867012

Rev-YFP
Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

39691

47086

45067

439483823

5

43049

44495

43976

43840732

15

53997

55800

71524

604409641

30

66701

59863

85225

7059613122

60

51804

70757

83764

6877516072
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Table 2: YFP-C and RevM6-YFP
YFP

Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

38886

43384

35123

391374136

5

45127

64700

37158

4899514173

15

59620

47642

62298

565207804

30

64025

46460

67131

5920511147

60

66847

48647

64676

600669925

RevM6-YFP
Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

39845

41135

53116

446987318

5

54252

56194

40986

504778277

15

56084

57087

63461

588774001

30

58453

54364

75378

6273211141

60

75421

56548

74965

6897810767
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Table 3: YFP-C & RevM4-YFP

YFP

Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

38314

36987

41757

390202462

5

39147

32150

40685

373274549

15

55989

38857

56142

503299936

30

61071

51460

57181

565714834

60

64430

45280

55058

549239576

RevM4-YFP
Recovery
Time

Trial 1

Trial 2

Trial 3

Average

0

30155

26956

37028

313805147

5

42806

35350

47094

417505943

15

44923

34065

62498

4716214348

30

63033

46614

65644

5843010316

60

70321

62372

66683

664593979
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